A sequential cohort study evaluating single‐agent KappaMab and KappaMab combined with lenalidomide and low‐dose dexamethasone in relapsed and/or refractory kappa light chain‐restricted multiple…

Overview of attention for article published in British Journal of Haematology, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 8,259)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 73 news outlets
twitter: 11 X users

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 9 Mendeley

Summary News X Wikipedia Dimensions citations

So far, Altmetric has seen 1 Wikipedia article.

English

MDX-1097

Cited by user 161.8.226.169 on 26 Mar 2024

MDX-1097 (formerly called IST-1097, now called KappaMab) is a monoclonal antibody therapy that has most recently been assessed in a Phase IIb clinical trial (2023) in…

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.